Machine learning and cloud computing are transforming computer-aided drug design (CADD) into an even more powerful tool for both medical and basic-science research. The mission of the Durrant lab at the University of Pittsburgh is to develop broadly applicable, innovative CADD techniques and to use those techniques to study infectious diseases and cancer. The biologically active molecules we identify also serve as small-molecule probes that shed light on protein functions in cells. Click here to learn more about our research.
